January 2007

Douglas A. McIntyre | Jan 11, 2007 at 6:05 AM EST

Europe Markets 1/11/2007 Prudential, Alcatel-Lucent Up

Stocks: (BCS)(BT)(BP)(GSK)(UN)(PUK)(RTRSY)(VOD)(BAY)(DCX)(DB)(DT)(SAP)(SI)(ALU)(AXA)(FTE)(V) Markets in Europe were up modestly at 6 AM New York time. The FTSE rose .4% to 6,188.…

Douglas A. McIntyre | Jan 11, 2007 at 5:35 AM EST

24/7 Wall St 2007 Price Targets: Exxon, $75.

Over the next week 24/7 Wall St. will set mid-year price targets (June, 30, 2007) for the sixty most widely…

Douglas A. McIntyre | Jan 11, 2007 at 5:07 AM EST

As Sony Playstation3 Underperfroms In Japan, Prospects Fade

Sales of the Playstation3 have fallen well short of expectations in the critical Japanese market Research firm Enterbrain says that…

Douglas A. McIntyre | Jan 11, 2007 at 4:46 AM EST

Media Digest 1/11/2007 NYTimes, WSJ, Reuters, Barron’s, FT

According to Reuters, management at Nokia (NOK) said that the sales goals for the Apple (AAPL) iPhone are not very…

Douglas A. McIntyre | Jan 11, 2007 at 4:21 AM EST

Asia Markets 1/11/2007 Cathay Pacific Up, China Unicom Down Sharply

Stocks: (CHL)(CHU)(CN)(PCW)(HBC) Markets in Asia were down. The Nikkei fell .6% to 16,838. The Hang Seng was down .9% to…

Douglas A. McIntyre | Jan 11, 2007 at 4:09 AM EST

Blockbuster Lays Out Growth Targets

By Chad Brand of Peridot Capitallist Blockbuster (BBI) CEO John Antioco, speaking at an investor conference yesterday, said his company…

Douglas A. McIntyre | Jan 11, 2007 at 4:06 AM EST

Reiterating A Buy On Altria (MO)

By Yaser Anwar, CSC of Equity Investment Ideas On Dec. 5th I talked about catalysts that make Altria a buy.…

Douglas A. McIntyre | Jan 11, 2007 at 4:04 AM EST

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INSMED INC [INSM] +22.33% LEV PHARMACEUTICALS [LEVP.OB] +15.11% ACCENTIA BIOPHARMACE [ABPI] +11.39% NEURALSTEM INC [NRLS.OB] +10.17%…

Douglas A. McIntyre | Jan 11, 2007 at 4:02 AM EST

Cephalon: Rare Biopharmaceutical Value Play for 2007

From BioHealth Investor In December, biopharmaceutical company Cephalon Inc. (CEPH) made the announcement that it has reduced its debt levels…

Douglas A. McIntyre | Jan 11, 2007 at 4:01 AM EST

Genomic Health, Insmed Lead as Biotechs Gain

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Both the Nasdaq (^NBI) and Amex (^BTK) biotech stock indices gained on Wednesday…

Douglas A. McIntyre | Jan 11, 2007 at 3:59 AM EST

Howard Stern’s $83 million Bonus

From Contrarian Edge By Vitaliy Katsenelson I have tremendous respect for The Financial Times. It is a great newspaper and…

Douglas A. McIntyre | Jan 11, 2007 at 2:30 AM EST

Cramer’s Retail Turnarounds; Plus a Visit on “Fast Money”

Last night on CNBC’s MAD MONEY, Jim Cramer said he had two picks as turnaround names that are retail plays. …

Douglas A. McIntyre | Jan 10, 2007 at 8:44 PM EST

Cramer Visited “FAST MONEY”; Look Out!

Stock Tickers: ICE, AH, HON, RAD, JNJ, CSCO, AAPL, SHLD, AA, PETM, SKS, GOOG Tonight was a different show on…

Douglas A. McIntyre | Jan 10, 2007 at 7:23 PM EST

Cisco Systems Sues Apple Over iPhone

Cisco Systems (CSCO) is suing Apple (AAPL) over the iPhone, but keep in mind that this has no impact on…

Douglas A. McIntyre | Jan 10, 2007 at 7:00 PM EST

Why The iPhone Won’t Work: Cisco Owns The Name

The press has been full of speculation about the new Apple (AAPL) iPhone. The range of opinion runs from Apple…

1 … 36 37 38 39 40 … 56

Month: January 2007

Europe Markets 1/11/2007 Prudential, Alcatel-Lucent Up

24/7 Wall St 2007 Price Targets: Exxon, $75.

As Sony Playstation3 Underperfroms In Japan, Prospects Fade

Media Digest 1/11/2007 NYTimes, WSJ, Reuters, Barron’s, FT

Asia Markets 1/11/2007 Cathay Pacific Up, China Unicom Down Sharply

Blockbuster Lays Out Growth Targets

Reiterating A Buy On Altria (MO)

Wednesday’s Top Biotech and Medical Stocks

Cephalon: Rare Biopharmaceutical Value Play for 2007

Genomic Health, Insmed Lead as Biotechs Gain

Howard Stern’s $83 million Bonus

Cramer’s Retail Turnarounds; Plus a Visit on “Fast Money”

Cramer Visited “FAST MONEY”; Look Out!

Cisco Systems Sues Apple Over iPhone

Why The iPhone Won’t Work: Cisco Owns The Name

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Europe Markets 1/11/2007 Prudential, Alcatel-Lucent Up

24/7 Wall St 2007 Price Targets: Exxon, $75.

As Sony Playstation3 Underperfroms In Japan, Prospects Fade

Media Digest 1/11/2007 NYTimes, WSJ, Reuters, Barron’s, FT

Asia Markets 1/11/2007 Cathay Pacific Up, China Unicom Down Sharply

Blockbuster Lays Out Growth Targets

Reiterating A Buy On Altria (MO)

Wednesday’s Top Biotech and Medical Stocks

Cephalon: Rare Biopharmaceutical Value Play for 2007

Genomic Health, Insmed Lead as Biotechs Gain

Howard Stern’s $83 million Bonus

Cramer’s Retail Turnarounds; Plus a Visit on “Fast Money”

Cramer Visited “FAST MONEY”; Look Out!

Cisco Systems Sues Apple Over iPhone

Why The iPhone Won’t Work: Cisco Owns The Name

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.